1. Home
  2. PPHC vs TARA Comparison

PPHC vs TARA Comparison

Compare PPHC & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PPHC

Public Policy Holding Company Inc. Common Stock

N/A

Current Price

$12.24

Market Cap

307.9M

Sector

N/A

ML Signal

N/A

Logo Protara Therapeutics Inc.

TARA

Protara Therapeutics Inc.

HOLD

Current Price

$5.84

Market Cap

268.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PPHC
TARA
Founded
N/A
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
307.9M
268.5M
IPO Year
2026
2014

Fundamental Metrics

Financial Performance
Metric
PPHC
TARA
Price
$12.24
$5.84
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$21.00
AVG Volume (30 Days)
118.7K
923.3K
Earning Date
N/A
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
39.22
EPS
N/A
N/A
Revenue
N/A
$2,948,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.75
$2.77
52 Week High
$13.00
$7.82

Technical Indicators

Market Signals
Indicator
PPHC
TARA
Relative Strength Index (RSI) 47.67 43.74
Support Level $11.93 $4.95
Resistance Level $12.93 $7.62
Average True Range (ATR) 0.38 0.48
MACD -0.01 -0.12
Stochastic Oscillator 42.23 24.55

Price Performance

Historical Comparison
PPHC
TARA

About TARA Protara Therapeutics Inc.

Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).

Share on Social Networks: